Sandbox:MGS: Difference between revisions

Jump to navigation Jump to search
No edit summary
No edit summary
Line 1: Line 1:
==Classification Based on ==
===Pathogenesis===
==Malignant Tumors==
Most breast cancers are epithelial tumors that develop from cells lining ducts or lobules; less common are nonepithelial cancers of the supporting stroma (eg, angiosarcoma, primary stromal sarcomas, phyllodes tumor).<ref name = kk> Breast Cancer. Merck Manual (2015) http://www.merckmanuals.com/professional/gynecology-and-obstetrics/breast-disorders/breast-cancer Accessed on January 18, 2016</ref>
*90–95% of all breast cancers in women occur sporadically.
*Breast cancer pathogenesis in combination with exogenous factors such as diet, alcohol and pollution, as well as endogenous factors such as estrogens and progesterone exposures contributes to it.


{| style="border: 0px; font-size: 90%; margin: 3px; width: 800px"
===Genetics===
|valign=top|
Five to ten percent of all breast cancers arise from germ-line mutations in breast cancer susceptibility genes such as BRCA1, BRCA2, p53 and PTEN.<ref name="pmid24665149">{{cite journal| author=Abdulkareem IH| title=Aetio-pathogenesis of breast cancer. | journal=Niger Med J | year= 2013 | volume= 54 | issue= 6 | pages= 371-5 | pmid=24665149 | doi=10.4103/0300-1652.126284 | pmc=PMC3948957 | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=24665149  }} </ref>
|+
The BRCA1 gene is located on the long arm of chromosome 17, while BRCA2 is located on the long arm of chromosome 13. Gene-positive patients have an 80% risk of developing breast cancer especially in the pre-menopausal age group.
! style="background: #4479BA; width: 150px;" | {{fontcolor|#FFF|Type}}
*The HER-2/neu proto-oncogene amplified and over-expressed in 20–30% of invasive breast cancers, and is associated with poorer outcome and shortened survival.
! style="background: #4479BA; width: 300px;" | {{fontcolor|#FFF|Subtype}}
 
|-
===Associated Conditions===
| style="padding: 5px 5px; background: #DCDCDC; font-weight: bold" |
 
'''Adenocarcinoma'''<ref name = class> Breast Neoplasm. Radiopedia. (2015) http://radiopaedia.org/articles/breast-neoplasms Accessed on January 16, 2016</ref>
===Gross Pathology===
|-
 
| style="padding: 5px 5px; background: #DCDCDC; font-weight: bold" |
===Microscopic Pathology===
'''Ductal'''
| style="padding: 5px 5px; background: #F5F5F5;" |
*Ductal carcinoma in situ (DCIS)
:*comedo type: ~60% of DCIS
:*non comedo type: ~40% of DCIS
::*papillary
::*micropapillary
::*cribriform
::*solid
:*intracystic papillary carcinoma in situ
*'''invasive ductal carcinoma'''
:*invasive ductal carcinoma not otherwise specified (NOS): ~65%
:*tubular carcinoma of breast: ~7-8%
::*tubulolobular carcinoma of breast
:*medullary carcinoma of breast (MCB): ~2%
:*mucinous (colloid) carcinoma: ~2%
:*malignant papillary lesions of the breast
::*papillary carcinoma of breast: 1-2% 1
|-
| style="padding: 5px 5px; background: #DCDCDC; font-weight: bold" |
'''Lobular'''
| style="padding: 5px 5px; background: #F5F5F5;" |
*lobular carcinoma in situ (LCIS)
*invasive lobular carcinoma: ~10%
|-
| style="padding: 5px 5px; background: #DCDCDC; font-weight: bold" |
'''Other malignant breast tumors'''
| style="padding: 5px 5px; background: #F5F5F5;" |
*inflammatory carcinoma of breast: 1-4%
*Paget disease of the nipple
*triple negative and basal-like breast cancers
*metaplastic carcinoma of the breast
*adenoid cystic carcinoma of the breast: <0.4%
*apocrine carcinoma of the breast
|-
| style="padding: 5px 5px; background: #DCDCDC; font-weight: bold" |
'''Sarcoma'''
| style="padding: 5px 5px; background: #F5F5F5;" |
*angiosarcoma of the breast
*fibrosarcoma of breast
*extra-skeletal osteosarcoma of breast
*malignant phyllodes tumor
*angiosarcoma
*rhabdomyosarcoma
|-
| style="padding: 5px 5px; background: #DCDCDC; font-weight: bold" |
'''Lymphoma'''
| style="padding: 5px 5px; background: #F5F5F5;" |
*Non-hodgkin lymphoma
|-
| style="padding: 5px 5px; background: #DCDCDC; font-weight: bold" |
'''Metastases to the breast'''
| style="padding: 5px 5px; background: #F5F5F5;" |
The most common extra-mammary cancers that metastasise to breast are:
*[[lymphoma]]/[[leukaemia]]: most common extra mammary source
*[[melanoma]]
*[[sarcomas]]
*[[prostate cancer]]: considered on the most frequent primary sites in men 4
*[[lung cancer]]
*[[gastric cancer]]
*[[ovarian cancer]]
*[[renal cell cancer]]
|-
|}

Revision as of 07:05, 19 January 2016

Pathogenesis

Most breast cancers are epithelial tumors that develop from cells lining ducts or lobules; less common are nonepithelial cancers of the supporting stroma (eg, angiosarcoma, primary stromal sarcomas, phyllodes tumor).[1]

  • 90–95% of all breast cancers in women occur sporadically.
  • Breast cancer pathogenesis in combination with exogenous factors such as diet, alcohol and pollution, as well as endogenous factors such as estrogens and progesterone exposures contributes to it.

Genetics

Five to ten percent of all breast cancers arise from germ-line mutations in breast cancer susceptibility genes such as BRCA1, BRCA2, p53 and PTEN.[2] The BRCA1 gene is located on the long arm of chromosome 17, while BRCA2 is located on the long arm of chromosome 13. Gene-positive patients have an 80% risk of developing breast cancer especially in the pre-menopausal age group.

  • The HER-2/neu proto-oncogene amplified and over-expressed in 20–30% of invasive breast cancers, and is associated with poorer outcome and shortened survival.

Associated Conditions

Gross Pathology

Microscopic Pathology

  1. Breast Cancer. Merck Manual (2015) http://www.merckmanuals.com/professional/gynecology-and-obstetrics/breast-disorders/breast-cancer Accessed on January 18, 2016
  2. Abdulkareem IH (2013). "Aetio-pathogenesis of breast cancer". Niger Med J. 54 (6): 371–5. doi:10.4103/0300-1652.126284. PMC 3948957. PMID 24665149.